CordLife Pte. Ltd. (CBB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

CordLife Pte. Ltd. (Cordlife) is a publicly held healthcare company engaged in collection, processing and storing cord blood stem cells to be used as potential source material for life saving treatment at a later stage. The company collects cord blood, also known as 'placental blood used to treat more than 80 diseases including blood and metabolic disorders, immunodeficiency ailments and autoimmune diseases. CordLife offers the world’s only fully automated cord blood processing system, Sepax, with a storage capacity for more than 50,000 stem cell units. The geographic operations of the company are spread across the Asia including Australia, India, Indonesia, Macau, Hong Kong, Singapore, Philippines and Thailand. CordLife is headquartered in Melbourne, Australia.

CordLife Pte. Ltd. (CBB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Year, 2006 to YTD 2012 4
CordLife Pte. Ltd., Pharmaceuticals and Healthcare Deals By Type, 2006 to YTD 2012 5
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Region, 2006 to YTD 2012 6
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2006 to YTD 2012 7
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012 8
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012 9
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals Summary, 2006 to YTD 2012 10
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deal Details 11
Partnerships 11
CyGenics Enters Into Joint Venture With PT Kalbe Farma 11
Equity Offering 12
Cordlife Group Announces Public Offering Of Shares For $23 Million 12
Acquisition 14
PT Kalbe Farma Acquires 48.98% Stake In P.T. CordLife From CyGenics 14
CyGenics Sells Cell Sciences To DNAPro 15
CyGenics Acquires Minority Stake In Pharmacell 16
CordLife Pte. Ltd. - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations and Subsidiaries 19
Recent Developments 20
Product News 20
Nov 09, 2006: Cygenics On Track To Launch Cord Blood Banking Services In India In 2007 20
Aug 06, 2007: Cordlife Hong Kong Achieves Iso 9001:2000 Certification 20
Feb 06, 2009: Immediate Release Cordlife First In Hong Kong To Implement Worlds Most Preferred Automated Cord Blood Processing 21
Jan 14, 2009: Cordlife Opens Medan Representative Office To Meet Growing Demands 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables

CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Key Facts, 2011 1
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Year, 2006 to YTD 2012 1
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Region, 2006 to YTD 2012 1
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2006 to YTD 2012 1
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Year, 2006 to YTD 2012 4
CordLife Pte. Ltd., Pharmaceuticals and Healthcare Deals By Type, 2006 to YTD 2012 5
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Region, 2006 to YTD 2012 6
CordLife Pte. Ltd., Deals By Therapy Area, 2006 to YTD 2012 7
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012 8
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012 8
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012 9
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Partnerships, Deals By Therapy Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012 9
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals Summary, 2006 to YTD 2012 10
CyGenics Enters Into Joint Venture With PT Kalbe Farma 11
Cordlife Group Announces Public Offering Of Shares For $23 Million 12
PT Kalbe Farma Acquires 48.98% Stake In P.T. CordLife From CyGenics 14
CyGenics Sells Cell Sciences To DNAPro 15
CyGenics Acquires Minority Stake In Pharmacell 16
CordLife Pte. Ltd., Key Competitors 17
CordLife Pte. Ltd., Key Employees 18
CordLife Pte. Ltd., Other Locations 19

List of Figures

CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals by Type, 2006 to YTD 2012 1
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Year, 2006 to YTD 2012 4
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals by Type, 2006 to YTD 2012 5
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Region, 2006 to YTD 2012 6
CordLife Pte. Ltd., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2006 to YTD 2012 7

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2014 Update

BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • May 2014
  • by Global Data

Summary BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal injuries and diseases which include orthopedics, ...

ApaTech Limited SWOT Analysis, Strategy, Revenues and Profits

ApaTech Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Golden Meditech Holdings Limited (Symbol:0801) SWOT Analysis, Strategy, Revenues and Profits

Golden Meditech Holdings Limited (Symbol:0801) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Glycorex Transplantation Ab

August 2014 $ 55

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.